Carbamazepine/βCD/HPMC solid dispersions. I. Influence of the spray-drying process and βCD/HPMC on the drug dissolution profile

Drug Development and Industrial Pharmacy

Volumn 29, Issue 2, 2003, Pages 139-144

  Koester, Letícia S ^a   Mayorga, Paulo ^a   Bassani, Valquiria L ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; CARBAMAZEPINE; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; ANTICONVULSIVE AGENT; BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; DRUG DERIVATIVE; METHYLCELLULOSE;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DISPERSION; DRUG ABSORPTION; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL CHEMISTRY; SIDE EFFECT; SOLID STATE; SPRAY DRYING; TABLET COMPRESSION; CHEMISTRY; COMPARATIVE STUDY; DRUG DOSAGE FORM; METHODOLOGY; PHARMACEUTICS; SOLUBILITY; TIME;

ANTICONVULSANTS; BETA-CYCLODEXTRINS; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DOSAGE FORMS; DRUG COMPOUNDING; EXCIPIENTS; METHYLCELLULOSE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 0037216070     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120016721     Document Type: Article

References (20)

1. USPDI, 17thEd.; Rockville, 1997; Vol. 1, 714-720.
2. Levy, R.H.; Wilensky, A.J.; Anderson, G.D. Carbamazepine, valproic acid, phenobarbital, and ethosuximide. In Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring, 3rd Ed.; Evans, W.E., Schentag, J.J., Jusko, W.J., Eds.; Applied Therapeutics: Vancouver, 1992; 26-1-26-29.
3. El-Nahhas, S.A. Physico-chemical characteristics of carbamazepine-β-cyclodextrin inclusion compounds and carbamazepine-PEG solid dispersions. Pharmazie 1996, 51 (12), 960-963.
4. Betlach, C.J.; Gonzales, M.A.; McKiernan, B.C.; Neff-Davis, C.; Bodor, N. Oral pharmacokinetics of carbamazepine in dogs from commercialtablets and a cyclodextrin complex. J. Pharm. Sci. 1993, 82 (10), 1058-1060.
5. Brewster, M.E.; Anderson, W.R.; Meinsma, D.; Moreno, D.; Webb, A.I.; Pablo, L.; Estes, K.S.; Derendorf, H.; Bodor, N.; Sawchuk, R.; Cheung, B.; Pop, E. Intravenous and oral pharmacokinetics evaluation of a 2-hydroxypropyl-β-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J. Pharm. Sci. 1997, 86 (3), 335-339.
6. El-Zein, H.; Riad, L.; El-Bary, A.A. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int. J. Pharm. 1998, 168, 209-220.
7. Giunchedi, P.; Maggi, L.; Conte, U.; La Manna, A. Linear extended release of a water-insoluble drug, carbamazepine, from erodible matrices. Int. J. Pharm. 1993, 94, 15-22.
8. Ikinci, G.; Capan, Y.; Senel, S.; Dalkara, T.; Hincal, A.A. Formulation and in vitro/in vivo investigation of carbamazepine controlledrelease matrix tablets. Pharmazie 1999, 54 (2), 139-141.
9. Takenaka, H.; Kawashima, Y.; Lin, S.-Y. Preparation of enteric-coated microcapsules for tableting by spray-drying technique and in vitro simulation of drug release from the tablet in GI tract. J. Pharm. Sci. 1980, 69 (12), 1388-1392.
10. Broadhead, J.; Rouan, S.K.E.; Rhodes, C.T. The spray-drying of pharmaceuticals. Drug Dev. Ind. Pharm. 1992, 18 (11-12), 1169-1206.
11. Wan, L.S.C.; Heng, P.W.S.; Chia, C.G.H. Spray drying as a process for microencapsulation and the effect of different coating polymers. Drug Dev. Ind. Pharm. 1992, 18 (9), 997-1011.
12. Kristmundsdóttir, T.; Gudmundsson, Ó.S.; Ingvarsdóttir, K. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int. J. Pharm. 1996, 137, 159-165.
13. Palmieri, G.F.; Wehrlé, P.; Stamm, A. Evaluation of spray-drying as a method to prepare microparticles for controlled drug release. Drug Dev. Ind. Pharm. 1994, 20 (18), 2859-2879.
14. Clarke, N.; O'Connor, K.; Ramtoola, Z. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying. Drug Dev. Ind. Pharm. 1998, 24 (2), 169-174.
15. Ermis, D.; Yürksel, A. Preparation of spray-dried microspheres of indomethacin and examination of the effects of coating on dissolution rates. J. Microencapsulation 1999, 16 (3), 315-324.
16. Wan, L.S.C.; Heng, P.W.S.; Chia, C.G.H. Preparation of coated particles using a spray drying process with an aqueous system. Int. Journal of Pharmaceutics 1991, 77, 183-191.
17. International conference on the harmonization of technical requirements for the registration of pharmaceuticals for human use (ICH) Q2B. Validation of analytical procedures. Methodology, 1996.
18. Conte, U.; Conti, B.; Giunchedi, P.; Maggi, L. Spray dried polylactide microsphere preparation: influence of the technological parameters. Drug Dev. Ind. Pharm. 1994, 20 (3), 235-258.
19. Bitz, C.; Doelker, E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int. J. Pharm. 1996, 131, 171-181.
20. López, C.R.; Fernández, M.J.A. Microencapsulación de medicamentos. In Tecnología Farmaceutica. Aspectos Fundamentales de los Sistemas Farmacéuticos y Operaciones Básicas; Jato, J.L.V., Ed.; Sintesis: Madrid, 1997; Vol. I, 577-608.